Phase 4 COPD and Suboptimal Inspiratory Flow Rate

NCT05165485 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

404

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Revefenacin
DRUG: Tiotropium
DRUG: Revefenacin Placebo
DRUG: Tiotropium Placebo

Sponsor

Theravance Biopharma

Collaborators

[object Object]